ArTS Archivio della ricerca di Trieste

Crocè, Saveria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.110
EU - Europa 6.631
AS - Asia 5.089
SA - Sud America 766
AF - Africa 201
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
Totale 23.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.848
SG - Singapore 1.968
IT - Italia 1.460
CN - Cina 1.393
PL - Polonia 1.238
SE - Svezia 831
HK - Hong Kong 719
BR - Brasile 614
UA - Ucraina 605
DE - Germania 592
GB - Regno Unito 324
FI - Finlandia 299
RU - Federazione Russa 261
VN - Vietnam 257
FR - Francia 197
BG - Bulgaria 192
NL - Olanda 185
CA - Canada 177
TR - Turchia 177
KR - Corea 163
IE - Irlanda 162
IN - India 96
CH - Svizzera 65
AR - Argentina 62
MA - Marocco 58
BD - Bangladesh 57
MX - Messico 55
SN - Senegal 54
BE - Belgio 45
JP - Giappone 37
IQ - Iraq 36
AT - Austria 32
ES - Italia 31
EG - Egitto 26
ZA - Sudafrica 26
EC - Ecuador 25
PK - Pakistan 24
CZ - Repubblica Ceca 22
ID - Indonesia 22
LT - Lituania 20
IR - Iran 18
PY - Paraguay 14
RO - Romania 14
CO - Colombia 13
KE - Kenya 12
PH - Filippine 12
SA - Arabia Saudita 12
AU - Australia 11
CL - Cile 11
DK - Danimarca 10
EU - Europa 10
UZ - Uzbekistan 10
IL - Israele 9
JO - Giordania 8
LK - Sri Lanka 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
TN - Tunisia 7
VE - Venezuela 7
BO - Bolivia 6
ET - Etiopia 6
GR - Grecia 6
KZ - Kazakistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
AM - Armenia 4
KG - Kirghizistan 4
NG - Nigeria 4
PE - Perù 4
PT - Portogallo 4
SI - Slovenia 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CU - Cuba 2
EE - Estonia 2
GA - Gabon 2
GY - Guiana 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 23.805
Salva come PNG Salva come JPEG
Città #
Warsaw 1.070
Ashburn 1.059
Singapore 976
Woodbridge 969
Fairfield 933
Ann Arbor 875
Houston 830
Chandler 828
Hong Kong 707
Jacksonville 555
Wilmington 459
Trieste 456
Seattle 432
Hefei 381
Beijing 340
Cambridge 304
Princeton 259
Boardman 241
San Jose 241
Sofia 192
Los Angeles 166
Dublin 158
Seoul 155
Dallas 153
Columbus 151
Izmir 151
Zgierz 143
London 138
Toronto 113
Munich 106
Moscow 104
Santa Clara 87
Milan 83
Ho Chi Minh City 82
Buffalo 79
Dearborn 79
New York 76
Helsinki 74
Frankfurt am Main 70
San Diego 66
São Paulo 60
Falls Church 58
Dakar 54
Düsseldorf 53
The Dalles 53
Bern 52
Hanoi 50
Chicago 49
Casablanca 46
Rome 44
Venezia 42
Brussels 40
Dong Ket 40
Redmond 40
Turku 39
Redwood City 38
Des Moines 36
Phoenix 33
Denver 30
Nuremberg 30
Udine 30
Krefeld 29
Redondo Beach 29
Montreal 28
Tokyo 28
Amsterdam 27
Atlanta 26
Orem 26
Stockholm 26
Shanghai 25
Verona 25
Vienna 25
Boston 23
Mexico City 23
Rio de Janeiro 22
Bremen 20
Grafing 20
Brooklyn 19
Chennai 19
Guangzhou 19
Mestre 19
Norwalk 19
Jinan 18
Lauterbourg 17
Mumbai 17
Portsmouth 17
San Francisco 17
Washington 17
Belo Horizonte 16
Johannesburg 16
Kunming 16
Poplar 16
Roubaix 16
Venice 16
Ottawa 15
Wroclaw 15
Dhaka 14
Fremont 14
Oklahoma City 14
Baghdad 13
Totale 16.039
Salva come PNG Salva come JPEG
Nome #
MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response 449
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 405
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 381
Adverse reactions of direct-acting antiviral agents in HCV patients: Our experience 361
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 357
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 357
The Role of Liver and Spleen Elastography in the Screening of Esophageal Varices in Patients with Liver Cirrhosis: Do We Really Need Endoscopy? 348
Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography 345
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 315
Gut microbiota characterisation in obese patients before and after bariatric surgery 296
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 247
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 245
Anatomy of Basal Ganglia and Thalamus 241
CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response 230
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 228
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 224
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 222
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 219
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 218
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 216
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression 212
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 204
Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. 200
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 198
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 194
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 192
Semi-automatic Approach to Estimate the Degree of Non-alcoholic Fatty Liver Disease (NAFLD) from Ultrasound Images 192
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 190
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 186
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 183
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 183
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 182
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 181
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 180
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 180
Hepatitis B virus genotypes, core promoter variants, and precore stop codonvariants in patients infected chronically in North-Eastern Italy. 176
Visual impairments and attention in parkinson's disease 174
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study 173
Stem cells in the development of hepatocellular carcinoma: identification and expression 172
Distribution of stem cells and cancer stem cells markers in liver pathologies and their indication to the response of therapy 172
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 172
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 171
HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection 169
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients 168
Treatment options in Western hepatocellular carcinoma: A prospective study of 224 patients 167
Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue and liver diseases 167
Cross talk between multipotent stem-like cells and cancer cells in hepatocellular carcinoma 166
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 165
Analysis of p53 and ras gene mutations in hepatocellular carcinoma from a Western country 163
PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY 161
Spontaneous rectal perforation in a patient with SARS–CoV-2 infection 158
The role of elastography in alcoholic liver disease: fibrosis staging and confounding factors, a review of the current literature 158
Diverticular Disease and Rifaximin: An Evidence-Based Review 157
Deep brain stimulation of the subthalamus: Neuropsychological effects 156
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19 152
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients 151
Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1 150
Clinical update on non-alcoholic fatty liver disease and steatohepatitis 148
Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease 147
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology. 2009 Oc FI, 9;9:75. 147
null 146
Evaluation with contrast enhanced US of perfusion changes in untreatable hepatocellular carcinoma after thalidomide administration: preliminary results 146
Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis 146
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature 144
null 143
Aspirin and Infection: A Narrative Review 143
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 141
A story of liver and gut microbes: How does the intestinal flora affect liver disease? A review of the literature 141
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis 136
Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based framework 136
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma 135
null 133
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test 133
Severity of liver disease with different hepatitis C viral clones. 131
Antibody pattern of HCV infection and hepatocellular carcinoma in Itakly: A case control study 130
Behind the Decrease of Liver Stiffness After Successful Hepatitis C Virus Eradication with Direct-Acting Antiviral Agents 130
null 129
null 129
Spontaneous porto-femoral shunting in long-standing portal hypertension 127
null 125
Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery 125
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View 124
Cirrosi biliare primitiva (CBP) asintomatica: trattamento con acido ursidesossicolico (UDCA). Risultati preliminari dopo 12 mesi. 123
Clinical and virological features of acute HBV-related hepatitis in southern vietnam 123
Characterization of focal liver lesions by pulse inversion harmonic imaging (PIHI) with Levovist in patients with cirrhosis. 122
Incidence and natural history of hepatocellular carcinoma and liver cirrhosis in Italy. A lesson from Trieste 120
null 119
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 119
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 118
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 118
Assessing the feasibility of AI-based Hamaguchi score estimation for NAFLD diagnosis using ultrasound images 116
Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience 114
Evaluation of liver parenchymal blood flow with contrast-enhanced US: preliminary results in healthy and cirrhotic patients 112
Predicting response to non-selective beta-blockers with liver–spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices 110
null 110
null 110
Calprotectin and SARS-CoV-2: A brief-report of the current literature 110
The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations 109
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma 108
null 107
Totale 17.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.084 0 0 0 0 0 0 184 198 106 215 120 261
2021/20221.868 60 98 226 204 58 133 103 126 213 167 103 377
2022/20232.513 216 280 167 346 224 454 55 263 321 38 96 53
2023/20241.574 116 90 73 101 171 135 270 314 30 50 130 94
2024/20253.648 64 71 199 364 325 336 318 189 472 490 377 443
2025/20265.415 1.124 555 696 921 946 869 304 0 0 0 0 0
Totale 24.548